Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in Neisseria gonorrhoeae.

Frontiers in Immunology
Serena BettoniAnna M Blom


Neisseria gonorrhoeae is the etiological agent of gonorrhea, the second most common bacterial sexually transmitted infection worldwide. Reproductive sequelae of gonorrhea include infertility, ectopic pregnancy and chronic pelvic pain. Most antibiotics currently in clinical use have been rendered ineffective due to the rapid spread of antimicrobial resistance among gonococci. The developmental pipeline of new antibiotics is sparse and novel therapeutic approaches are urgently needed. Previously, we utilized the ability of N. gonorrhoeae to bind the complement inhibitor C4b-binding protein (C4BP) to evade killing by human complement to design a chimeric protein that linked the two N-terminal gonococcal binding domains of C4BP with the Fc domain of IgM. The resulting molecule, C4BP-IgM, enhanced complement-mediated killing of gonococci. Here we show that C4BP-IgM induced membrane perturbation through complement deposition and membrane attack complex pore insertion facilitates the access of antibiotics to their intracellular targets. Consequently, bacteria become more susceptible to killing by antibiotics. Remarkably, C4BP-IgM restored susceptibility to azithromycin of two azithromycin-resistant clinical gonococcal strains because ...Continue Reading


May 1, 1978·Antimicrobial Agents and Chemotherapy·B S DutcherR K Cunningham
Jan 1, 1992·Antimicrobial Agents and Chemotherapy·H Pruul, P J McDonald
Mar 11, 1991·Vaccine·J W BoslegoS W Wood
Oct 1, 1990·The Journal of Infectious Diseases·R P Darveau, M D Cunningham
Nov 1, 1972·Infection and Immunity·H Pruul, B L Reynolds
Jan 1, 1994·Methods in Enzymology·D P McQuillenP A Rice
Nov 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·Emma Andersson NordahlArtur Schmidtchen
May 10, 2011·FEBS Letters·Jean-Michel BollaJean-Marie Pagès
Jan 9, 2014·International Journal of STD & AIDS·C BignellUNKNOWN European STI Guidelines Editorial Board
May 24, 2014·Clinical and Experimental Immunology·A M BlomM Okroj
Jul 2, 2014·Clinical Microbiology Reviews·Magnus Unemo, William M Shafer
Feb 14, 2015·European Journal of Clinical Investigation·Dimitrios C MastellosJohn D Lambris
Mar 1, 2015·Molecular Immunology·Evelien T M BerendsSuzan H M Rooijakkers
Nov 12, 2015·Biochimica Et Biophysica Acta·Daniela XhindoliAlessandro Tossi
Mar 8, 2016·Current Medicinal Chemistry·Hannah Y MahmoodKhondaker M Rahman
Dec 26, 2017·The Lancet Infectious Diseases·Evelina TacconelliUNKNOWN WHO Pathogens Priority List Working Group
Feb 13, 2018·Nature Reviews. Microbiology·Sarah Jane Quillin, H Steven Seifert
Sep 30, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jutamas ShaughnessySanjay Ram
Jan 10, 2019·The New England Journal of Medicine·Aik-Kah Tan
Feb 20, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joanne ReekieUNKNOWN Chlamydia and Reproductive Health Outcome Investigators
May 24, 2019·Methods in Molecular Biology·Sunita GulatiSanjay Ram
Jul 16, 2019·MedChemComm·M Rhia L StoneMark A T Blaskovich
Aug 7, 2019·Bulletin of the World Health Organization·Jane RowleyMelanie M Taylor
Nov 23, 2019·Nature Reviews. Disease Primers·Magnus UnemoJo-Anne R Dillon
Dec 25, 2019·International Journal of STD & AIDS·Helen FiferMark FitzGerald
Feb 19, 2020·The Journal of Antimicrobial Chemotherapy·Pham Thi LanMagnus Unemo
Mar 21, 2020·The American Journal of Pathology·Catherine B XieJordan S Pober
Aug 14, 2020·The Journal of Antimicrobial Chemotherapy·Daniel GolparianUNKNOWN Brazilian-GASP Network
Oct 31, 2020·International Journal of STD & AIDS·M UnemoJ S Jensen
Dec 18, 2020·MMWR. Morbidity and Mortality Weekly Report·Sancta St CyrPhoebe Thorpe
Aug 31, 2021·RSC Chemical Biology·M Rhia L StoneMark A T Blaskovich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.